Floatz logo

Raav1.Cmv.Hufollistatin344

Becker Muscular Dystrophy

Nationwide Children's Hospitalgene_therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Becker Muscular Dystrophy cohort.

Asset / SponsorPhaseRating
(-)-Epicatechin
Craig McDonald, MD
Phase 2BB
CARVEDILOL
Catholic University, Italy
Phase 4BB
Tadalafil
Cedars-Sinai Medical Center
Phase 4BB
Ataluren
PTC Therapeutics
Phase 3BB
RAMIPRIL
Catholic University, Italy
Phase 4B

View all 19 →

Same molecule, other indications

Raav1.Cmv.Hufollistatin344 is also rated in:

Duchenne muscular dystrophyDormant
CCC
Indicative ·
48 / 100
View asset →
inclusion body myositisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →